PULSE POINTS:
❓What Happened: The House Judiciary Committee is investigating claims that Pfizer executives delayed COVID-19 vaccine trial results to influence the 2020 election.
👥 Who’s Involved: Philip Dormitzer, Pfizer’s former head of vaccine research and development; the House Judiciary Committee; federal prosecutors; and GSK (GlaxoSmithKline).
📍 Where & When: Allegations stem from 2020, with ongoing investigations in 2025.
💬 Key Quote: Dormitzer reportedly stated, “Let’s just say it wasn’t a coincidence, the timing of the vaccine.”
⚠️ Impact: The investigation could reveal whether Pfizer acted to impact the 2020 presidential election, and may lead to further scrutiny of the pharma giant’s practices.
IN FULL:
The House Judiciary Committee has launched an investigation into allegations that Pfizer executives deliberately slowed COVID-19 vaccine clinical trials to influence the outcome of the 2020 presidential election. The claims center on comments made by Philip Dormitzer, Pfizer’s former head of vaccine research and development.
According to Dormitzer, Pfizer’s top research executives intentionally delayed the completion of clinical testing, ensuring results would not be available before the election. Dormitzer reportedly told colleagues at his subsequent employer, GlaxoSmithKline (GSK), that the timing of the vaccine’s release was “not a coincidence.” GSK later passed this information to federal prosecutors in New York.
The Judiciary Committee, chaired by Rep. Jim Jordan, has demanded that Dormitzer provide all relevant documents related to Pfizer’s vaccine trials from March 1, 2020, to the present. Dormitzer has also been asked to schedule a transcribed interview with the committee by May 29. Dormitzer reportedly requested a transfer to Canada after Trump’s 2024 re-election, citing fears of investigation.
Positive trial results, if disclosed earlier, could have politically benefited President Donald J. Trump, then serving his first term. Trump has previously accused Pfizer and the U.S. Food and Drug Administration (FDA) of withholding vaccine success to hinder his 2020 re-election campaign.